Home » KV PHARMACEUTICAL EXPANDS BORROWING CAPACITY
KV PHARMACEUTICAL EXPANDS BORROWING CAPACITY
KV Pharmaceutical has additional borrowing capacity with its lenders after amending its loan agreements late last month, it said in a regulatory filing. The company amended its loan with LaSalle Bank through Dec. 20, 2005, and increased its borrowing capacity for acquisitions from $25 million to $30 million. In addition, it doubled the amount of credit for acquisitions under a loan with LaSalle and Citibank from $30 million to $60 million.
St. Louis Business Journal (http://www.bizjournals.com/stlouis/stories/2005/01/17/daily28.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct